
Profitability, historical returns, and peer comparisons.
According to NanoViricides, Inc.’s latest financial reports and current stock price. The company's current ROE is -91.11%. This represents a change of 294.93% compared to the average of -23.07% of the last 4 quarters.
The mean historical ROE of NanoViricides, Inc. over the last ten years is -65.41%. The current -91.11% ROE has changed 39.29% with respect to the historical average. Over the past ten years (40 quarters), NNVC's ROE was at its highest in in the March 2021 quarter at -6.61%. The ROE was at its lowest in in the March 2020 quarter at -56.47%.
Average
-65.41%
Median
-59.79%
Minimum
-125.93%
Maximum
-29.49%
Discovering the peaks and valleys of NanoViricides, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 74.06%
Maximum Annual ROE = -29.49%
Minimum Annual Increase = -52.27%
Minimum Annual ROE = -125.93%
| Year | ROE | Change |
|---|---|---|
| 2026 | -94.65% | -24.84% |
| 2025 | -125.93% | 74.06% |
| 2024 | -72.35% | 25.23% |
| 2023 | -57.77% | 64.50% |
| 2022 | -35.12% | 19.08% |
| 2021 | -29.49% | -52.27% |
| 2020 | -61.80% | -20.54% |
| 2019 | -77.78% | 60.44% |
| 2018 | -48.48% | -4.39% |
| 2017 | -50.71% | 8.97% |
The current ROE of NanoViricides, Inc. (NNVC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-97.64%
5-year avg
-77.17%
10-year avg
-65.41%
NanoViricides, Inc.’s ROE is greater than Verrica Pharmaceuticals Inc. (-444.44%), greater than Jasper Therapeutics, Inc. (-618.87%), greater than SAB Biotherapeutics, Inc. (-6.74%), greater than Generation Bio Co. (-50.53%), greater than Evaxion Biotech A/S (-61.39%), greater than IGC Pharma, Inc. (-113.58%), less than Q32 Bio Inc. (76.88%), greater than MAIA Biotechnology, Inc. (-211.15%), greater than AN2 Therapeutics, Inc. (-53.52%), greater than Tenax Therapeutics, Inc. (-61.55%),
| Company | ROE | Market cap |
|---|---|---|
| -444.44% | $58.67M | |
| -618.87% | $17.96M | |
| -6.74% | $299.80M | |
| -50.53% | $35.98M | |
| -61.39% | $19.01M | |
| -113.58% | $19.83M | |
| 76.88% | $255.72M | |
| -211.15% | $68.53M | |
| -53.52% | $167.74M | |
| -61.55% | $47.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NanoViricides, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NanoViricides, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NanoViricides, Inc.'s ROE?
How is the ROE calculated for NanoViricides, Inc. (NNVC)?
What is the highest ROE for NanoViricides, Inc. (NNVC)?
What is the 3-year average ROE for NanoViricides, Inc. (NNVC)?
What is the 5-year average ROE for NanoViricides, Inc. (NNVC)?
How does the current ROE for NanoViricides, Inc. (NNVC) compare to its historical average?